This opportunity is no longer accepting applications.
grant PAR-23-169

Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

This grant opportunity is for funding early-stage, high-risk, high-impact research on new vaccine approaches to prevent or treat HIV infections. It involves a Go/No-Go funding approach, meaning continued funding depends on meeting specific criteria by the end of the second year.

The purpose of this reissued Funding Opportunity Announcement (FOA) is to support high-risk, high-impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high-risk, high-impact nature of this research, this FOA supports a …

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases
Program: SBIR

Awards & funding

Award Ceiling: $350,000
Award Amount: $350,000

Dates

Opportunity Released: April 20, 2023
Open for Submission: April 20, 2023
Submission Deadline: August 1, 2025
Application Window Closes: August 1, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.